|
| 36646618 | The Need to Reduce Variability in the Study of Blood Pressure Variability. | Am J Kidney Dis | 2023 |
| 37345834 | Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials. | J Am Heart Assoc | 2023 |
| 36996297 | Midodrine Is an Effective Therapy for Resistant Intradialytic Hypotension: COMMENTARY. | Kidney360 | 2023 |
| 37092336 | Hypertension in Patients Treated With In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities: A Scientific Statement From the American Heart Association. | Hypertension | 2023 |
| 37027509 | Role of Finerenone in Contemporary Clinical Care for Diabetic Kidney Disease. | Clin J Am Soc Nephrol | 2023 |
| 36519451 | Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial. | Hypertension | 2023 |
| 36621637 | International Consensus on Standardized Clinic Blood Pressure Measurement - A Call to Action. | Am J Med | 2023 |
| 34622281 | Blood Pressure Variability: Not to Be Discounted. | Am J Hypertens | 2022 |
| 35737275 | Cardiovascular and Renal Outcomes with Finerenone, a Selective Mineralocorticoid Receptor Antagonist. | Cardiol Ther | 2022 |
| 36815107 | Associations of Serum and Dialysate Potassium Concentrations With Incident Atrial Fibrillation in a Cohort Study of Older US Persons Initiating Hemodialysis for Kidney Failure. | Kidney Int Rep | 2022 |
| 36326747 | Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease. | JAMA | 2022 |
| 35167875 | Letter regarding "diagnosis and treatment of arterial hypertension 2021". | Kidney Int | 2022 |
| 32711070 | Outcomes Among Patients With Left Ventricular Assist Devices Receiving Maintenance Outpatient Hemodialysis: A Case Series. | Am J Kidney Dis | 2021 |
| 35373003 | Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial. | Kidney360 | 2021 |
| 33769679 | The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial. | Diabetes Obes Metab | 2021 |
| 33561218 | Ultrafiltration rate and incident atrial fibrillation among older individuals initiating hemodialysis. | Nephrol Dial Transplant | 2021 |
| 33637204 | Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States. | Kidney Int | 2021 |
| 33637203 | Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. | Kidney Int | 2021 |
| 33554616 | Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights From the CREDENCE Trial. | Circulation | 2021 |
| 34674811 | Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study. | J Am Coll Cardiol | 2021 |
| 34277971 | Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program. | Endocrinol Diabetes Metab | 2021 |
| 34152826 | Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline. | Ann Intern Med | 2021 |
| 34320842 | Intensive Blood Pressure Control and Diabetes Mellitus-Related Limb Events in Patients With Type 2 Diabetes Mellitus: Reanalysis of ACCORD. | J Am Heart Assoc | 2021 |
| 33957619 | Comparison of Pre-Amputation Evaluation in Patients with and without Chronic Kidney Disease. | Am J Nephrol | 2021 |
| 34365808 | SPRINT-A Kidney-Centric Narrative Review: Recent Advances in Hypertension. | Hypertension | 2021 |
| 33980041 | Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association. | Circulation | 2021 |
| 33316351 | Intradialytic Hypotension and Newly Recognized Peripheral Artery Disease in Patients Receiving Hemodialysis. | Am J Kidney Dis | 2021 |
| 33422263 | Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial. | Lancet Respir Med | 2021 |
| 33358942 | Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial. | Am Heart J | 2021 |
| 31053433 | Outcomes after left ventricular assist device implantation in patients with acute kidney injury. | J Thorac Cardiovasc Surg | 2020 |
| 35378029 | Is There Any Role for Device Therapies in Resistant Hypertension? Commentary. | Kidney360 | 2020 |
| 35369376 | Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease. | Kidney360 | 2020 |
| 31931418 | Central venous pressure and the risk of diuretic-associated acute kidney injury in patients after cardiac surgery. | Am Heart J | 2020 |
| 33131314 | Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT). | Hypertension | 2020 |
| 32661684 | A Call for a New Paradigm for Diabetes Care in the Era of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i). | Cardiol Ther | 2020 |
| 32937008 | Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol. | J Clin Hypertens (Greenwich) | 2020 |
| 32811639 | Does really central venous pressure affect the risk of diuretic-associated acute kidney injury after cardiac surgery? | Am Heart J | 2020 |
| 32393466 | How We Manage Hypertension in a Patient with a Recent Stroke. | Clin J Am Soc Nephrol | 2020 |
| 32362229 | Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation. | Hypertension | 2020 |
| 30449517 | Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD. | Am J Kidney Dis | 2019 |
| 32734229 | Sodium Excretion and Cardiovascular Outcomes in African American Patients With CKD: Findings From the African American Study of Kidney Disease and Hypertension. | Kidney Med | 2019 |
| 31440746 | Estimated effects of early diuretic use in critical illness. | Crit Care Explor | 2019 |
| 31175104 | Blood Pressure and Incident Atrial Fibrillation in Older Patients Initiating Hemodialysis. | Clin J Am Soc Nephrol | 2019 |
| 31256717 | Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT. | Hypertension | 2019 |
| 31307270 | Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT. | J Am Heart Assoc | 2019 |
| 30836447 | Timing of blood pressure medications and intradialytic hypotension. | Semin Dial | 2019 |
| 31150512 | Patterns of diuretic use in the intensive care unit. | PLoS One | 2019 |
| 31010478 | Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. | Kidney Int | 2019 |
| 31116155 | Comparison of routine and automated office blood pressure measurement. | Blood Press Monit | 2019 |
| 30852913 | Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. | Circulation | 2019 |